Anxiety, which is frequently comorbid with depression, is the largest mental health issue in North America. It is estimated that one third of the North American adult population experiences anxiety issues, yet only one third of sufferers receive treatment, of whom only 10% experience any form of remission. This is largely due to limitations in current therapies. Anxiety affects 48 million patients in the United States. The US market for anxiety prescriptions was $8.4 billion last year. The global market for anxiety medications was $13.7 billion last year. In 2018, there were approximately 140 million prescriptions of anxiety medications in the United States. (1)

(1)  IQVIA market data – 2018